Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2172 of 5804
-
New hope for tough prostate cancer? drug trial targets resistant tumors
Disease control Not yet recruitingThis is a single-arm, open-label phase 2 study to evaluate the role of pacritinib for patients with metastatic castrate-resistant prostate cancer that have progressed on ARSI. Patients will receive pacritinib 200 mg twice daily. To be eligible, patients must have a biopsy of a me…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Smart knee could help veterans walk better
Symptom relief Not yet recruitingMicroprocessor-controlled knees (MPKs) automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The purpose of this proposed investigation is to determine if there are substantial phy…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Mindfulness may help caregivers move more and reduce heart risks
Symptom relief Not yet recruitingOver 80% of caregivers for individuals with neurodegenerative diseases (ND) engage in significant risk behaviors, particularly physical inactivity, which increases the risk of cardiometabolic diseases (CMD) by 30% and reduces life expectancy by 4-8 years. Despite the health benef…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can fish oil fight lupus inflammation? new study aims to find out
Disease control Not yet recruitingThis randomized, double-blind, placebo-controlled clinical trial aims to evaluate whether oral omega-3 fatty acid supplementation can modulate inflammation, oxidative stress, and telomere maintenance in women with systemic lupus erythematosus (SLE) in remission. Women aged 18-45 …
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Light flicker therapy aims to sharpen aging brains
Symptom relief Not yet recruitingThe goal is to determine whether three months of at least three times / week of sensory flicker stimulation improves cognition, mobility, and affect in healthy older adults and older adults with and without Subjective Cognitive Decline (SCD). Investigators will also determine whe…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Tuning in to relief: music therapy app tested for sickle cell pain
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a 4-week music therapy (MT) intervention can reduce chronic pain and improve psychosocial outcomes in youth with sickle cell disease (SCD). The main questions it aims to answer are: * Does MT reduce pain intensity, frequenc…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New antibody drug takes aim at rheumatoid arthritis in first human trial
Disease control Not yet recruitingThis is a Phase 1, open-label, first-in-human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of KT502 administered subcutaneously to participants with Rheumatoid Arthritis (RA). The study will have 2 parts: Part A is a single ascending dose f…
Phase: PHASE1 • Sponsor: Kali Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Shock therapy may keep kids dry longer
Disease control Not yet recruitingParacascral transcutaneous electrical nerve stimulation (PTENS) is a credible therapeutic option for nocturnal enuresis. The investigators shall investigate whether maintenance PTENS after initial response improves durability of remission compared with observation alone.
Phase: NA • Sponsor: Suez Canal University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
AI chatbot aims to ease cancer Patients' trauma
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a trauma-informed, artificial intelligence-supported chatbot can reduce psychological distress and unmet psychosocial needs in adults newly diagnosed with cancer.: * Does the chatbot reduce trauma-related distress and anxiet…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Exercise program aims to restore strength after dengue and chikungunya
Symptom relief Not yet recruitingIntroduction: Dengue and Chikungunya arboviral diseases are considered major public health challenges in tropical regions due to high infection rates and the occurrence of musculoskeletal sequelae that impair strength, balance, and functionality. After the acute phase, symptoms s…
Phase: NA • Sponsor: Universidade do Estado do Pará • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New COPD inhaler shows promise in early trial
Disease control Not yet recruitingThis is a multicenter, randomized, open-label, positive-drug controlled study designed to evaluate the preliminary efficacy and safety of different doses of TQC3927 inhaled powder for short-term treatment of patients with chronic obstructive pulmonary disease, and to observe the …
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple hormone boost pregnancy chances for overweight women?
Symptom relief Not yet recruitingThis study aims to explore whether the application of low-dose HCG in luteal support can improve the pregnancy outcomes of natural cycle frozen embryo transfer in obese patients
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can a special diet help control diabetes? new study tests Low-Calorie MIND-HK plan
Disease control Not yet recruitingThe objective of this project is to assess the effectiveness of a low-calorie and very low-calorie Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND-HK) diet in improving glycemic control and cardiovascular outcomes in adults with T2DM. A total of 180 participants…
Phase: NA • Sponsor: Hong Kong Metropolitan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could hand therapy replace surgery for carpal tunnel?
Symptom relief Not yet recruitingCarpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy and can cause pain, numbness, tingling, and functional impairment of the hand. Although surgical decompression is considered an effective treatment for moderate CTS, there is increasing interest in c…
Phase: NA • Sponsor: Universidad Europea de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Phone app aims to ease anxiety in breast cancer survivors
Symptom relief Not yet recruitingDigital mental and behavioral health interventions have potential to significantly improve accessibility for the large number of breast cancer survivors who need treatments. However, the landscape of digital interventions tested in this population remains limited, with the few th…
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New Long-Acting numbing shot could ease pain after major abdominal surgery
Symptom relief Not yet recruitingThis is a single-center, randomized, controlled, double-blind clinical trial. A total of 148 patients undergoing elective open upper abdominal surgery will be included and randomly assigned 1:1 to receive ultrasound-guided erector spinae plane block with liposome bupivacaine plus…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New cancer drug candidate SHR-4685 enters first human tests
Disease control Not yet recruitingThe study is being conducted to evaluate the safety, tolerability and pharmacokinetics of SHR-4685 in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Hypnosis as a hospital treatment for gut disorders?
Symptom relief Not yet recruitingThe purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will b…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can learning to listen to your heart improve life with heart disease?
Symptom relief Not yet recruitingAdults living with congenital heart disease (CHD) commonly experience physical symptoms alongside emotional and social challenges, which can affect wellbeing and health-related quality of life. Access to psychological services varies, and evidence to guide the development and del…
Phase: NA • Sponsor: University of Glasgow • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Ancient oil pulling gets a modern test against plaque and gingivitis
Disease control Recruiting nowThe goal of this study is to scientifically evaluate the efficacy of this oil pulling oral rinse in reducing dental plaque, gingival inflammation, gingival bleeding, and selectively reducing caries- and periodontal disease-associated bacteria compared to a marketed mouthwash and …
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC